Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension

Alcon Research30 enrolled

Overview

This is a multiple-dose study of the IOP-lowering efficacy of Azopt (brinzolamide) 1.0% compared to timolol 0.5% when added to a prostaglandin analogue (PGA) as adjunctive therapy over a 24 hour period in patients with glaucoma or ocular hypertension.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Primary Open Angle Glaucoma Ocular Hypertension

Interventions

brinzolamide 1.0%DRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Primary open angle glaucoma or ocular hypertension patients Exclusion Criteria: * Women of childbearing potential * History of bronchial asthma, or severe chronic obstructive pulmonary disease * Presence of acute glaucoma

Locations (1)

Unnamed facility

San Diego, California, United States

Outcomes

Primary Outcomes

IOP-lowering at 8 and 16 weeks

Secondary Outcomes

Safety throughout the 16 weeks of the study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.